Canlyniadau chwilio am the

View our response to the Welsh Government’s consultation on the mandatory licensing of special procedures in Wales

This report contains the HCPC’s first scientific assessment of the time new HCPC registrants stayed registered for

Rachael is the Deputy Superintendent Radiographer at St George's University Hospitals in London

The data for both these reports is from the snapshot date of 5 April in the preceding year (2022).

This policy sets out the HCPC’s approach to checking applications for plagiarism as part of the international registration process.

Health for Health Professionals Wales (HHP Wales) - since the pandemic began, the service has expanded to offer signposting to a range of support for NHS staff, students and volunteers

The standards to enable registered orthoptists who are appropriately trained to sell and supply certain prescription only medicines

This report provides information about the HPC’s work in considering allegations about the Fitness to Practise of registrants.

Key facts and figures of our work in protecting the public and promoting professionalism

This report provides information about the HCPC’s work in considering allegations about the fitness to practise of HCPC registrants. 

This report provides information about the HCPC’s work in considering allegations about the fitness to practise of HCPC registrants. 

This data primarily relates to the application of the previous (or legacy) model, which was discontinued at the end of the 2020-21 academic year, and replaced by the new model.

This report provides highlights from the data set produced, focusing on time and quality wherever possible.

Health and Care Professions Council response to NHS England’s consultation on the proposal for the supply and administration of medicines using patient group directions for biomedical scientists across the United Kingdom.

Health and Care Professions Council response to NHS England’s consultation on proposed amendments to the list of medicines that paramedics are able to administer under exemptions within the Human Medicines Regulations 2012 across the United Kingdom.